U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117136) titled 'Blinatumomab Consolidation in Real World' on Aug. 05.
Brief Summary: This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical & Translational Science Institute.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
B-Cell Acute Lymphoblastic Leukaemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Medical College of Wisconsin
Information provided by (Responsible Party): Ehab L Atallah, Medical College of Wisconsin
Published...